Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
The Faces of Luminex: Joern Mosner, Assay R&D
When you think about research and development at a company like Luminex, your mind probably goes straight to the instruments we produce — the sophisticated technology platforms like our ARIES® System. However, those systems wouldn’t be nearly as valuable to customers without having top-notch assays to run on them, and that’s where Joern Mosner, Vice President of Assay R&D, comes in.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference
January 24
Luminex Corporation Declares First Quarter Cash Dividend
January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017
ESPID
28 May – 2 June
Malmo, Sweden
PSI Annual Meeting
3-6 June
Beurs Van Berlage, Amsterdam
Drug Discovery Summit
7-8 June
Berlin, Germany
KIT
20-23 June
Cologne, Germany
ESM
1-4 July
Dresden, Germany
